AGARWALEYE Dr. Agarwal's Health Care Q1 FY26 results (Apr–Jun 2025) and concall
Dr. Agarwal's Health Care Limited announced the proposed merger of its subsidiary, Dr. Agarwal's Eye Hospital, into the parent entity. The merger, intended to streamline operations and enhance financial efficiencies, involves a share swap ratio of 23 AHCL shares for every 2 AEHL shares, representing a 15% premium to AEHL's 10-day VWAP. However, the announcement was met with significant concerns from several minority shareholders of AEHL, who argued the swap ratio was unfair and undervalued their holdings, raising questions about the valuation process and corporate governance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 255 | 268 | 281 | 302 |
| EBITDA | 58 | 65 | 73 | 67 |
| Net profit | -4 | 8 | 27 | 10 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
